Catalyst Clinical Research Revenue and Competitors

Location

#9760

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Catalyst Clinical Research's estimated annual revenue is currently $134.5M per year.(i)
  • Catalyst Clinical Research's estimated revenue per employee is $201,000

Employee Data

  • Catalyst Clinical Research has 669 Employees.(i)
  • Catalyst Clinical Research grew their employee count by 15% last year.

Catalyst Clinical Research's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Executive Director, Business DevelopmentReveal Email/Phone
4
SVP, Business OperationsReveal Email/Phone
5
Data Protection OfficerReveal Email/Phone
6
VP, Oncology Drug DevelopmentReveal Email/Phone
7
VP, Clinical Development OperationsReveal Email/Phone
8
SVP, Strategy and SolutionsReveal Email/Phone
9
VP Project ManagementReveal Email/Phone
10
SVP, Clinical Development OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$295.7M19085%N/AN/A
#2
$243.2M12106%N/AN/A
Add Company

What Is Catalyst Clinical Research?

At Catalyst, our focus is to advance Biopharmaceutical, Device and Clinical Research Organizations'? development programs by providing flexible, customized, and cost effective research services comprised of targeted, seasoned and therapeutically-aligned expertise. From the engagement of a single clinical research professional to an entire clinical team, Catalyst is industry known as the proven and trusted outsourcing choice.

keywords:N/A

N/A

Total Funding

669

Number of Employees

$134.5M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Catalyst Clinical Research News

2022-04-17 - Moleculin obtains FDA clearance for Phase I glioma treatment ...

Moleculin Biotech is all set to commence Phase I clinical trial of ... Catalyst Clinical Research to conduct clinical trial of Annamycin,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M73910%N/A
#2
$162.6M809-4%N/A
#3
$142.7M859N/AN/A
#4
$411.6M891-1%N/A
#5
$35M89973%N/A